HCA Healthcare Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	7,853	7,782	6,657	6,091	6,834	7,721
Depreciation & Amortization	3,674	3,523	3,312	3,077	2,969	2,853
Stock-Based Compensation	375	401	360	262	341	440
Other Adjustments	-97	512	291	458	-470	-1,552
Change in Receivables	-1,831	-94	-799	-935	-797	-962
Changes in Inventories	247	-154	334	-126	-59	-540
Changes in Accounts Payable	903	666	604	359	-296	999
Operating Cash Flow	11,124	12,636	10,514	9,431	8,522	8,959
Operating Cash Flow Growth	-6.79%	20.18%	11.48%	10.67%	-4.88%	-2.96%
Capital Expenditures	-5,127	-4,944	-4,875	-4,744	-4,395	-3,577
Cash Acquisitions	-457	-397	-266	-635	-224	-1,105
Proceeds from Business Divestments	123	269	328	193	1,237	2,160
Other Investing Activities	-83	84	-120	-131	-7	-121
Investing Cash Flow	-5,544	-4,988	-4,933	-5,317	-3,389	-2,643
Short-Term Debt Issued	3,113	2,202	-1,880	-1,020	120	2,780
Net Short-Term Debt Issued (Repaid)	3,113	2,202	-1,880	-1,020	120	2,780
Long-Term Debt Issued	6,235	8,474	7,495	3,224	5,997	4,344
Long-Term Debt Repaid	-4,337	-7,389	-2,410	-909	-2,830	-3,869
Net Long-Term Debt Issued (Repaid)	1,898	1,085	5,085	2,315	3,167	475
Repurchase of Common Stock	-8,691	-10,067	-6,042	-3,811	-7,000	-8,215
Net Common Stock Issued (Repurchased)	-8,691	-10,067	-6,042	-3,811	-7,000	-8,215
Common Dividends Paid	-682	-679	-690	-661	-653	-624
Other Financing Activities	-1,138	-1,091	-1,055	-917	-1,290	-1,071
Financing Cash Flow	-5,500	-8,550	-4,582	-4,094	-5,656	-6,655
Foreign Exchange Rate Adjustments	-6	9	-1	7	-20	-3
Net Cash Flow	74	-893	998	27	-543	-342
Free Cash Flow	5,997	7,692	5,639	4,687	4,127	5,382
Free Cash Flow Growth	-17.76%	36.41%	20.31%	13.57%	-23.32%	-15.87%
FCF Margin	7.69%	10.17%	7.99%	7.21%	6.85%	9.16%
Free Cash Flow Per Share	26.18	32.12	21.54	16.96	14.01	16.37
Levered Free Cash Flow	11,548	9,162	8,340	5,103	7,149	9,946
Unlevered Free Cash Flow	9,302	8,561	7,613	6,175	5,430	7,334

SEC Filings: 10-K · 10-Q